Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001654954-21-007859
Filing Date
2021-07-13
Accepted
2021-07-13 16:35:31
Documents
1
Period of Report
2021-07-12

Document Format Files

Seq Description Document Type Size
1 PRIMARY DOCUMENT section16.html 4  
1 PRIMARY DOCUMENT section16.xml 4 3669
  Complete submission text file 0001654954-21-007859.txt   5009
Mailing Address 1000 SKOKIE BLVD SUITE 350 WILMETTE IL 60091
Business Address 1000 SKOKIE BLVD SUITE 350 WILMETTE IL 60091 8473880349
Monopar Therapeutics (Issuer) CIK: 0001645469 (see all company filings)

EIN.: 320463781 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address C/O 1000 SKOKIE BLVD SUITE 350 WILMETTE IL 60091
Business Address
Filho Jose Octavio Pinto Costa (Reporting) CIK: 0001863625 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-39070 | Film No.: 211088249